Scandinavian ChemoTech Stock

Scandinavian ChemoTech ROA 2024

Scandinavian ChemoTech ROA

-1.42

Ticker

CMOTEC B.ST

ISIN

SE0009242654

WKN

A2DGQ3

In 2024, Scandinavian ChemoTech's return on assets (ROA) was -1.42, a 35.33% increase from the -1.05 ROA in the previous year.

Scandinavian ChemoTech Aktienanalyse

What does Scandinavian ChemoTech do?

Scandinavian ChemoTech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Scandinavian ChemoTech's Return on Assets (ROA)

Scandinavian ChemoTech's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Scandinavian ChemoTech's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Scandinavian ChemoTech's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Scandinavian ChemoTech’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Scandinavian ChemoTech stock

What is the Return on Assets (ROA) of Scandinavian ChemoTech this year?

The Return on Assets (ROA) of Scandinavian ChemoTech is -1.42 undefined this year.

What was the ROA of Scandinavian ChemoTech compared to the previous year?

The ROA of Scandinavian ChemoTech has increased by 35.33% compared to the previous year.

What consequences do high ROA have for investors of Scandinavian ChemoTech?

A high ROA is advantageous for investors of Scandinavian ChemoTech, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Scandinavian ChemoTech?

A low ROA can be unfavorable for investors of Scandinavian ChemoTech as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Scandinavian ChemoTech affect the company?

An increase in ROA of Scandinavian ChemoTech can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Scandinavian ChemoTech impact the company?

A reduction in the ROA of Scandinavian ChemoTech can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Scandinavian ChemoTech?

Some factors that can influence the ROA of Scandinavian ChemoTech include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Scandinavian ChemoTech important for investors?

The ROA of Scandinavian ChemoTech is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Scandinavian ChemoTech take to improve ROA?

To improve ROA, Scandinavian ChemoTech can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Scandinavian ChemoTech pay?

Over the past 12 months, Scandinavian ChemoTech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Scandinavian ChemoTech is expected to pay a dividend of 0 SEK.

What is the dividend yield of Scandinavian ChemoTech?

The current dividend yield of Scandinavian ChemoTech is .

When does Scandinavian ChemoTech pay dividends?

Scandinavian ChemoTech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Scandinavian ChemoTech?

Scandinavian ChemoTech paid dividends every year for the past 0 years.

What is the dividend of Scandinavian ChemoTech?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Scandinavian ChemoTech located?

Scandinavian ChemoTech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Scandinavian ChemoTech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Scandinavian ChemoTech from 11/1/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Scandinavian ChemoTech pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Scandinavian ChemoTech in the year 2023?

In the year 2023, Scandinavian ChemoTech distributed 0 SEK as dividends.

In which currency does Scandinavian ChemoTech pay out the dividend?

The dividends of Scandinavian ChemoTech are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Scandinavian ChemoTech

Our stock analysis for Scandinavian ChemoTech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Scandinavian ChemoTech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.